港股異動︱贛鋒鋰業跌逾8% 遭東風資管減持346萬股
格隆匯3月9日丨贛鋒鋰業(1772.HK)現報28.85港元,跌8.12%,暫成交2.1億港元,最新總市值372.9億港元。根據聯交所最新資料顯示,3月5日,DONGFENG ASSET MANAGEMENT LTD減持贛鋒鋰業346萬股,每股作價33.0631港元,涉及總金額約為1.14億港元。減持後最新持股數目約為654萬股,最新持股比例3.27%。此前贛鋒鋰業曾公佈2019年度業績稱,期內實現營業總收入52.82億元(人民幣,下同),同比增長5.56%;歸屬於上市公司股東的淨利潤3.56億元,同比下降70.88%;基本每股收益0.28元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.